Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparing Optimal Step-down Therapy for Children With Invasive MRSA Trimethoprim-Sulfamethoxazole vs. Clindamycin for the Treatment of Children With Invasive MRSA Infections

NCT06982105 is registered in ClinicalTrials.gov with Indiana University as lead sponsor.

NCT NCT06982105
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06982105 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparing Optimal Step-down Therapy for Children With Invasive MRSA Trimethoprim-Sulfamethoxazole vs. Clindamycin for the Treatment of Children With Invasive MRSA Infections
Lead sponsor
Indiana University
Phase
Phase 4
Overall status
Recruiting
Start date
May 20, 2025
Completion date
June 30, 2027
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical adenitis, facial cellulitis, mastoiditis, methicillin resistant staphylococcus aureus, orbital cellulitis, osteomyelitis acute, peritonsillar abscess, retropharyngeal abscess, septic arthritis